8-Azaguanine: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{ | {{Short description|An antimetabolite and purine analog used in cancer treatment}} | ||
{{ | {{Drugbox | ||
| image = 8-azaguanine.png | |||
| image_size = 250px | |||
| image_alt = Chemical structure of 8-Azaguanine | |||
}} | |||
'''8-Azaguanine''' is a purine analog that has been studied for its potential use in cancer treatment. It is a derivative of | '''8-Azaguanine''' is a purine analog and antimetabolite that has been studied for its potential use in cancer treatment. It is a derivative of guanine, one of the four main nucleobases found in the nucleic acids DNA and RNA. | ||
==Chemical Structure | ==Chemical Structure== | ||
8-Azaguanine is | [[File:8-azaguanine.png|thumb|right|Chemical structure of 8-Azaguanine]] | ||
8-Azaguanine is structurally similar to guanine, with the primary difference being the substitution of a nitrogen atom in place of a carbon atom in the purine ring. This alteration allows 8-azaguanine to interfere with nucleic acid metabolism. | |||
==Mechanism of Action== | ==Mechanism of Action== | ||
8-Azaguanine acts as an antimetabolite by mimicking the structure of guanine. When incorporated into [[DNA]] or [[RNA]], it disrupts normal cellular processes, leading to the inhibition of [[nucleic acid]] synthesis. This disruption is particularly effective in rapidly dividing cells, such as cancer cells, making 8-azaguanine a potential chemotherapeutic agent. | |||
==Clinical Applications== | ==Clinical Applications== | ||
Although 8-azaguanine has shown promise in preclinical studies, its clinical use has been limited. Research has focused on its potential to treat various types of [[cancer]], including [[leukemia]] and [[lymphoma]]. However, the development of more effective and less toxic alternatives has overshadowed its use. | |||
==Side Effects | ==Side Effects== | ||
As with many chemotherapeutic agents, 8-azaguanine can cause a range of side effects. These may include [[myelosuppression]], gastrointestinal disturbances, and [[hepatotoxicity]]. The severity of side effects often depends on the dosage and duration of treatment. | |||
==Research and Development== | ==Research and Development== | ||
Research into 8-azaguanine continues, with studies exploring its mechanism of action, potential combination therapies, and ways to mitigate its side effects. Advances in [[pharmacogenomics]] may also provide insights into patient-specific responses to 8-azaguanine. | |||
==Related Pages== | ==Related Pages== | ||
* [[ | * [[Antimetabolite]] | ||
* [[Purine analog]] | * [[Purine analog]] | ||
* [[Chemotherapy]] | * [[Chemotherapy]] | ||
* [[Cancer treatment]] | * [[Cancer treatment]] | ||
[[Category:Antimetabolites]] | |||
[[Category:Purine analogs]] | |||
[[Category:Chemotherapy]] | |||
[[Category: | |||
[[Category: | |||
[[Category: | |||
Latest revision as of 03:42, 13 February 2025
An antimetabolite and purine analog used in cancer treatment
| 8-Azaguanine | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
8-Azaguanine is a purine analog and antimetabolite that has been studied for its potential use in cancer treatment. It is a derivative of guanine, one of the four main nucleobases found in the nucleic acids DNA and RNA.
Chemical Structure[edit]
8-Azaguanine is structurally similar to guanine, with the primary difference being the substitution of a nitrogen atom in place of a carbon atom in the purine ring. This alteration allows 8-azaguanine to interfere with nucleic acid metabolism.
Mechanism of Action[edit]
8-Azaguanine acts as an antimetabolite by mimicking the structure of guanine. When incorporated into DNA or RNA, it disrupts normal cellular processes, leading to the inhibition of nucleic acid synthesis. This disruption is particularly effective in rapidly dividing cells, such as cancer cells, making 8-azaguanine a potential chemotherapeutic agent.
Clinical Applications[edit]
Although 8-azaguanine has shown promise in preclinical studies, its clinical use has been limited. Research has focused on its potential to treat various types of cancer, including leukemia and lymphoma. However, the development of more effective and less toxic alternatives has overshadowed its use.
Side Effects[edit]
As with many chemotherapeutic agents, 8-azaguanine can cause a range of side effects. These may include myelosuppression, gastrointestinal disturbances, and hepatotoxicity. The severity of side effects often depends on the dosage and duration of treatment.
Research and Development[edit]
Research into 8-azaguanine continues, with studies exploring its mechanism of action, potential combination therapies, and ways to mitigate its side effects. Advances in pharmacogenomics may also provide insights into patient-specific responses to 8-azaguanine.
